Author:
Morrison Randall L.,Fedgchin Maggie,Singh Jaskaran,Van Gerven Joop,Zuiker Rob,Lim Kyoung Soo,van der Ark Peter,Wajs Ewa,Xi Liwen,Zannikos Peter,Drevets Wayne C.
Funder
Janssen Research and Development
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. aan het Rot M, Collins KA, Murrough JW, Perez AM, Reich DL, Charney DS, Mathew SJ (2010) Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression. Biol Psychiatry 67(2):139–145.
https://doi.org/10.1016/j.biopsych.2009.08.038
2. Andrade C (2015) Intranasal drug delivery in neuropsychiatry: focus on intranasal ketamine for refractory depression. J Clin Psychiatry 76:628–631
3. Bitter C (2011) Transmucosal nasal drug delivery: pharmacokinetics and pharmacodynamics of nasally applied esketamine. Dissertation, University of Basel
4. Collie A, Maruff P, McStephen M, Darby D (2003) Psychometric issues associated with computerised neuropsychological assessment of concussed athletes. Br J Sports Med 37(6):556–559.
https://doi.org/10.1136/bjsm.37.6.556
5. Daly E, Singh J, Fedgchin M, Cooper K, Lim P, Shelton RC, Thase ME, Winokur A, Van Nueten L, Manji H, Drevets WC (2017) Efficacy and safety of intranasal esketamine in treatment-resistant depression: results of a double-blind, doubly-randomized, placebo-controlled study. Am J Psychiatry. In press
Cited by
60 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献